Our blog will keep you informed of all the latest news and developments in the growing CBD industry. Alongside articles from the news, we will also keep you updated about what’s happening at Swiss Life Sciences Group.
Swiss Life Sciences Group Plc Announces Cannabis Technology Investment10. 5. 2021
Swiss Life Sciences Group Plc is a cannabis-sector private equity company based in London. It has been researching and identifying strategic investments in the fast-growing medical cannabis and phytocannabinoid industry since 2019 and is now focused on developing strategic acquisitions and investments in Switzerland. ...Read More
UK’s Largest Seed-to-Consumer CBD Manufacturer to Develop GMP-Certified CBD Facility18. 4. 2021
Swiss Life Sciences Group Plc is setting its sights on becoming one of the next-generation seed-to-consumer companies in the fast-growing medical cannabis and CBD wellness sectors. ...Read More
Swiss Life Sciences Group CBD – Disruption Through Transparency18. 4. 2021
Swiss Life Sciences Group has emerged as one of the largest seed-to-consumer, vertically integrated CBD manufacturers in the European market. Our company aims to provide a transparent and trustworthy network of brands to give consumers peace of mind, in an often unprincipled market. ...Read More